Level of mesothelin expression can indicate the prognosis of malignant pleural mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is a fatal, treatment-resistant tumor. The median survival of MPM is 9–12 months and its early prognostic markers remains uncertain. The objective of this study was to determine that the level of mesothelin expression can be as a predictor of prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Feifei, Zhang, Huanan, Zhang, Ying, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799090/
https://www.ncbi.nlm.nih.gov/pubmed/35117348
http://dx.doi.org/10.21037/tcr-19-2027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799090/
https://www.ncbi.nlm.nih.gov/pubmed/35117348
http://dx.doi.org/10.21037/tcr-19-2027

Ejemplares similares